News tagged with cyclooxygenase
Cyclooxygenase
Cyclooxygenase (COX) is an enzyme (EC 1.14.99.1) that is responsible for formation of important biological mediators called prostanoids, including prostaglandins, prostacyclin and thromboxane. Pharmacological inhibition of COX can provide relief from the symptoms of inflammation and pain. Non-steroidal anti-inflammatory drugs, such as aspirin and ibuprofen, exert their effects through inhibition of COX. The names "prostaglandin synthase (PHS)" and "prostaglandin endoperoxide synthetase (PES)" are still used to refer to COX.
For more information about Cyclooxygenase, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
New research discovers key to survival of brain cells
Nicolas G. Bazan, MD, Ph.D, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center New Orleans, and David Stark, an MD/Ph.D student working in his lab, have discovered how a key ...
Medicine & Health / Neuroscience
Sep 28, 2011 |
not rated yet |
0
Common anti-inflammatory coaxes liver cancer cells to commit suicide
The anti-inflammatory drug celecoxib, known by the brand name Celebrex, triggers liver cancer cell death by reacting with a protein in a way that makes those cells commit suicide, according to a new study.
May 16, 2011 |
4.3 / 5 (6) |
0
|
NSAID receptor responsible for olive oil's 'cough' and more
Scientists from the Monell Center and collaborators report that a receptor known as TRPA1 is activated by two structurally unrelated anti-inflammatory compounds. The first, oleocanthal, is a natural polyphenolic anti-inflammatory ...
Medicine & Health / Neuroscience
Jan 18, 2011 |
4.5 / 5 (4) |
0
Fluorescent compounds make tumors glow
A series of novel imaging agents could light up tumors as they begin to form - before they turn deadly - and signal their transition to aggressive cancers.
Apr 29, 2010 |
5 / 5 (3) |
0
|
Researchers detail how aging undermines bone healing
Researchers have unraveled crucial details of how aging causes broken bones to heal slowly, or not at all, according to study results published today in the Journal of Bone and Mineral Research. The research team also succes ...
Jan 15, 2009 |
4.6 / 5 (5) |
0
Organometallic compounds as new drugs? Cobalt-containing aspirin complex with potential anti-tumor properties
Despite considerable progress in modern chemotherapy, there remains a large demand for innovative anti-tumor agents. A new approach involves modeling the pharmacological properties of established drugs with organometallic ...
Jan 13, 2009 |
2.8 / 5 (6) |
0
